ערך בספרים למניה: Neumora Therapeutics (NMRA)

Neumora Therapeutics (NMRA) is a biopharmaceutical innovator developing precision CNS treatments powered by big data analytics. This daily price action reflects a market dynamic currently fixed at 0.24. The company is currently focused on clinical trials, utilizing internal reserves due to a lack of regular profits. Product commercialization is hindered by stringent insurance requirements, which temporarily deprives the company of its pricing power.
neumoratx.com - פילוחים אנליטיים ומדדי מפתח (NMRA)

The BVPS valuation analysis reflects the status of Neumora Therapeutics (NMRA) as a biotech issuer whose value is based on the capital deployed in the development of drugs for depression and schizophrenia. This indicator is calculated as the difference between all assets and liabilities divided by the number of shares, allowing an investor to assess the intrinsic value of the business and the resilience of its financial foundation against market volatility.